Results 141 to 150 of about 436,907 (393)
Spontaneous Rupture of Umbilical Hernia in an Infant [PDF]
Shane Strange
openalex +1 more source
Risk Factors for Surgical Complications in Ventral Hernia Repair
BackgroundThe aim of this study was to identify risk factors for an adverse event, i.e. early surgical complication, need for ICU care and readmission, following ventral hernia repair.
M. Lindmark+4 more
semanticscholar +1 more source
A novel, simple coccygeal intervertebral disc degeneration model, using a suturing method for tail‐looping, without the need for external fixation and complex surgery. The model has high reproducibility and stability and overcomes the disadvantages of the existing animal models of disc degeneration.
Wei Xie+11 more
wiley +1 more source
HERNIA OF THE BLADDER COMPLICATING INGUINAL HERNIA
n ...
openaire +3 more sources
Background Formin-like 2 (FMNL2) is a member of Formin family which governs cytokinesis, cellular polarity and morphogenesis. Dysregulation of FMNL2 has been discovered in cancers and is closely related to cancers.
Banghua Zhong+3 more
doaj +1 more source
SYMPTOMATIC PAROTITIS FOLLOWING STRANGULATED HERNIA. [PDF]
F. J. G. Jefferiss
openalex +1 more source
Syndrome of the Month: Bosma Arhinia Microphthalmia Syndrome
American Journal of Medical Genetics Part A, EarlyView.
Katherine J. K. Patterson+2 more
wiley +1 more source
Towards Polymer Composite‐Based Transient Electronic Systems
Biodegradable electronic systems are gaining attention for implantable biomedical applications, targeting disease treatment and lifespan extension. This review covers advances in biocompatible, biodegradable polymer composites using synthetic and natural polymers with conductive, semiconductive, and insulating fillers.
Gwan‐Jin Ko+5 more
wiley +1 more source
Objective: The aim of the study was to evaluate biosynthetic absorbable mesh in single-staged contaminated (Centers for Disease Control class II and III) ventral hernia (CVH) repair over 24 months.
M. Rosen+12 more
semanticscholar +1 more source
Objective To evaluate the applicability of the 2016 EULAR/ACR/PRINTO macrophage activation syndrome (MAS) classification criteria in patients with Still's disease (sJIA‐SD) treated with IL‐1‐targeted therapy and to assess the incidence of MAS in this context.
Remco G.A. Erkens+14 more
wiley +1 more source